{
  "pmcid": "12083446",
  "sha256": "07cf04fd1fb52c8f7b85dd98840677b7caec962c951742c130d576ba6b49e6ed",
  "timestamp_utc": "2025-11-09T23:26:10.109964+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.53475182481752,
    "reading_ease": 29.595923357664248,
    "word_count": 274
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Impact of Transit-Time Flow Measurement on Postoperative Outcomes in Coronary Artery Bypass Grafting: A Retrospective Analysis"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "910 patients undergoing isolated total arterial coronary artery bypass grafting with internal thoracic arteries (ITAs) at our institution between January 2017 and February 2020"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were divided based on the use of TTFM: 430 patients in the TTFM group and 480 in the no TTFM group"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the impact of transit-time flow measurement (TTFM) on early postoperative outcomes in total arterial coronary revascularization"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the occurrence of in-hospital major cardiac adverse events (MACE), including mortality, myocardial infarction, and need for revascularization"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "910 patients undergoing isolated total arterial coronary artery bypass grafting with internal thoracic arteries (ITAs) at our institution between January 2017 and February 2020"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Participants were divided based on the use of TTFM: 430 patients in the TTFM group and 480 in the no TTFM group"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "TTFM was protective against MACE occurrence (odds ratio 0.46, 95% CI 0.23â€“0.85, P = 0.016)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Six (1.4%) patients in the TTFM group underwent intraoperative graft revision due to unsatisfactory flow values, compared to none in the no TTFM group (P = 0.011)"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 14,
    "max_score": 25
  }
}